This title appears in the Scientific Report :
2021
Please use the identifier:
http://hdl.handle.net/2128/27820 in citations.
Please use the identifier: http://dx.doi.org/10.1021/acsmedchemlett.0c00658 in citations.
Radiosynthesis and Biological Evaluation of [18F]R91150, a Selective 5-HT2A Receptor Antagonist for PET-Imaging
Radiosynthesis and Biological Evaluation of [18F]R91150, a Selective 5-HT2A Receptor Antagonist for PET-Imaging
Serotonergic 5-HT2A receptors in cortical and forebrain regions are an important substrate for the neuromodulatory actions of serotonin in the brain. They have been implicated in the etiology of many neuropsychiatric disorders and serve as a target for antipsychotic, antidepressant, and anxiolytic d...
Saved in:
Personal Name(s): | Willmann, Michael |
---|---|
Hegger, Julian / Neumaier, Bernd (Corresponding author) / Ermert, Johannes | |
Contributing Institute: |
Nuklearchemie; INM-5 |
Published in: | ACS medicinal chemistry letters, 12 (2021) 5, S. 738 - 744 |
Imprint: |
Washington, DC
ACS
2021
|
DOI: |
10.1021/acsmedchemlett.0c00658 |
Document Type: |
Journal Article |
Research Program: |
Decoding Brain Organization and Dysfunction |
Link: |
Published on 2021-04-01. Available in OpenAccess from 2022-04-01. Restricted |
Publikationsportal JuSER |
Please use the identifier: http://dx.doi.org/10.1021/acsmedchemlett.0c00658 in citations.
LEADER | 05314nam a2200733 a 4500 | ||
---|---|---|---|
001 | 892695 | ||
005 | 20210623133504.0 | ||
024 | 7 | |a 10.1021/acsmedchemlett.0c00658 |2 doi | |
024 | 7 | |a 2128/27820 |2 Handle | |
024 | 7 | |a 34055220 |2 pmid | |
024 | 7 | |a WOS:000651790900010 |2 WOS | |
037 | |a FZJ-2021-02273 | ||
082 | |a 610 | ||
100 | 1 | |a Willmann, Michael |0 P:(DE-Juel1)173964 |b 0 |u fzj | |
245 | |a Radiosynthesis and Biological Evaluation of [18F]R91150, a Selective 5-HT2A Receptor Antagonist for PET-Imaging | ||
260 | |a Washington, DC |c 2021 |b ACS | ||
520 | |a Serotonergic 5-HT2A receptors in cortical and forebrain regions are an important substrate for the neuromodulatory actions of serotonin in the brain. They have been implicated in the etiology of many neuropsychiatric disorders and serve as a target for antipsychotic, antidepressant, and anxiolytic drugs. Positron emission tomography imaging using suitable radioligands can be applied for in vivo quantification of receptor densities and receptor occupancy for therapy evaluation. Recently, the radiosynthesis of the selective 5-HT2AR antagonist [18F]R91150 was reported. However, the six-step radiosynthesis is cumbersome and time-consuming with low radiochemical yields (RCYs) of <5%. In this work, [18F]R91150 was prepared using late-stage Cu-mediated radiofluorination to simplify its synthesis. The detailed protocol enabled us to obtain RCYs of 14 ± 1%, and the total synthesis time was reduced to 60 min. In addition, autoradiographic studies with [18F]R91150 in rat brain slices revealed the typical uptake pattern of 5-HT2A receptor ligands. | ||
588 | |a Dataset connected to CrossRef, Journals: juser.fz-juelich.de | ||
700 | 1 | |a Hegger, Julian |0 P:(DE-HGF)0 |b 1 | |
700 | 1 | |a Neumaier, Bernd |0 P:(DE-Juel1)166419 |b 2 |e Corresponding author | |
700 | 1 | |a Ermert, Johannes |0 P:(DE-Juel1)131818 |b 3 | |
773 | |a 10.1021/acsmedchemlett.0c00658 |g Vol. 12, no. 5, p. 738 - 744 |0 PERI:(DE-600)2532386-6 |n 5 |p 738 - 744 |t ACS medicinal chemistry letters |v 12 |y 2021 |x 1948-5875 | ||
856 | 4 | |y Published on 2021-04-01. Available in OpenAccess from 2022-04-01. |u http://juser.fz-juelich.de/record/892695/files/18FR91150%20Final%20Version.pdf | |
856 | 4 | |y Restricted |u http://juser.fz-juelich.de/record/892695/files/acsmedchemlett.0c00658%281%29.pdf | |
909 | C | O | |o oai:juser.fz-juelich.de:892695 |p openaire |p open_access |p VDB |p driver |p dnbdelivery |
910 | 1 | |a Forschungszentrum Jülich |0 I:(DE-588b)5008462-8 |k FZJ |b 0 |6 P:(DE-Juel1)173964 | |
910 | 1 | |a Forschungszentrum Jülich |0 I:(DE-588b)5008462-8 |k FZJ |b 1 |6 P:(DE-HGF)0 | |
910 | 1 | |a Forschungszentrum Jülich |0 I:(DE-588b)5008462-8 |k FZJ |b 2 |6 P:(DE-Juel1)166419 | |
910 | 1 | |a Forschungszentrum Jülich |0 I:(DE-588b)5008462-8 |k FZJ |b 3 |6 P:(DE-Juel1)131818 | |
913 | 0 | |a DE-HGF |b Key Technologies |l Decoding the Human Brain |1 G:(DE-HGF)POF3-570 |0 G:(DE-HGF)POF3-573 |3 G:(DE-HGF)POF3 |2 G:(DE-HGF)POF3-500 |4 G:(DE-HGF)POF |v Neuroimaging |x 0 | |
913 | 1 | |a DE-HGF |b Key Technologies |l Natural, Artificial and Cognitive Information Processing |1 G:(DE-HGF)POF4-520 |0 G:(DE-HGF)POF4-525 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-500 |4 G:(DE-HGF)POF |v Decoding Brain Organization and Dysfunction |x 0 | |
914 | 1 | |y 2021 | |
915 | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2021-01-28 | ||
915 | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2021-01-28 | ||
915 | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2021-01-28 | ||
915 | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2021-01-28 | ||
915 | |a Embargoed OpenAccess |0 StatID:(DE-HGF)0530 |2 StatID | ||
915 | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b ACS MED CHEM LETT : 2019 |d 2021-01-28 | ||
915 | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |d 2021-01-28 | ||
915 | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2021-01-28 | ||
915 | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2021-01-28 | ||
915 | |a IF < 5 |0 StatID:(DE-HGF)9900 |2 StatID |d 2021-01-28 | ||
915 | |a DBCoverage |0 StatID:(DE-HGF)1200 |2 StatID |b Chemical Reactions |d 2021-01-28 | ||
915 | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2021-01-28 | ||
915 | |a DBCoverage |0 StatID:(DE-HGF)0320 |2 StatID |b PubMed Central |d 2021-01-28 | ||
915 | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2021-01-28 | ||
980 | |a journal | ||
980 | |a VDB | ||
980 | |a UNRESTRICTED | ||
980 | |a I:(DE-Juel1)INM-5-20090406 | ||
980 | 1 | |a FullTexts | |
536 | |a Decoding Brain Organization and Dysfunction |0 G:(DE-HGF)POF4-525 |c POF4-525 |x 0 |f POF IV | ||
336 | |a ARTICLE |2 BibTeX | ||
336 | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1621516261_5765 |2 PUB:(DE-HGF) | ||
336 | |a Output Types/Journal article |2 DataCite | ||
336 | |a article |2 DRIVER | ||
336 | |a Nanopartikel unedler Metalle (Mg0, Al0, Gd0, Sm0) |0 0 |2 EndNote | ||
336 | |a JOURNAL_ARTICLE |2 ORCID | ||
920 | |l yes | ||
920 | |k Nuklearchemie; INM-5 |0 I:(DE-Juel1)INM-5-20090406 |l Nuklearchemie |x 0 | ||
990 | |a Willmann, Michael |0 P:(DE-Juel1)173964 |b 0 |u fzj | ||
991 | |a Ermert, Johannes |0 P:(DE-Juel1)131818 |b 3 | ||
991 | |a Neumaier, Bernd |0 P:(DE-Juel1)166419 |b 2 |e Corresponding author | ||
991 | |a Hegger, Julian |0 P:(DE-HGF)0 |b 1 |